In Narrow Vote, ODAC Votes Against Avastin In Breast Cancer
Oncologic Drugs Advisory Committee expresses concerns about overall survival, toxicity and study conduct.
Oncologic Drugs Advisory Committee expresses concerns about overall survival, toxicity and study conduct.